During the past decade, Advanced ENT and Allergy conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 20 clinical trials were completed, i.e. on average, 90.9% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 12 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Advanced ENT and Allergy" #1 sponsor was "Intersect ENT" with 7 trials, followed by "Otonomy, Inc." with 3 trials sponsored, "Cumberland Pharmaceuticals" with 2 trials sponsored, "Hill Dermaceuticals, Inc." with 2 trials sponsored and "Sound Pharmaceuticals, Incorporated" with 2 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Advanced ENT and Allergy" #1 collaborator was "Abond CRO Inc." with 1 trials as a collaborator, "Advance Research Associates" with 1 trials as a collaborator, "National Cancer Institute (NCI)" with 1 trials as a collaborator and "QST Consultations, Ltd." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Advanced ENT and Allergy" are "Chronic Sinusitis" (6 trials), "AOM - Acute Otitis Media" (2 trials), "Chronic Rhinitis" (2 trials), "Nasal Polyposis" (2 trials) and "OME - Otitis Media With Effusion" (2 trials). Many other conditions were trialed in "Advanced ENT and Allergy" in a lesser frequency.

Most popular intervention types in "Advanced ENT and Allergy" are "Drug" (17 trials), "Device" (11 trials), "Procedure" (6 trials), "Combination Product" (3 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "S8 Sinus Implant" (3 trials), "Balloon Sinus Dilation Alone" (2 trials), "Mometasone furoate nasal spray" (2 trials) and "OTO-313" (2 trials). Other intervention names were less common.

The vast majority of trials in "Advanced ENT and Allergy" are 31 trials for "All" genders.

Currently, there are NaN active trials in "Advanced ENT and Allergy". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in Advanced ENT and Allergy, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Advanced ENT and Allergy, 4 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 5 trials that are defined as “Not Applicable".